Co-Delivery of Daunorubicin and Homoharringtonine in Folic Acid Modified-Liposomes for Enhancing Therapeutic Effect on Acute Myeloid Leukemia

Cancer treatment and survivorship statistics, 2016

Kimberly D. Miller, Rebecca L. Siegel, Chun Chieh Lin et al. · CA A Cancer Journal for Clinicians · 2016 · 6.2K citations · Full text

Medicine, Oncology, Population Health Sciences +17

Folate receptor alpha as a tumor target in epithelial ovarian cancer

Kimberly R. Kalli, Ann L. Oberg, Gary L. Keeney et al. · Gynecologic Oncology · 2008 · 467 citations · Full text

Medicine, Cancer Biology, Oncology +11

First-In-Man Study of CPX-351: A Liposomal Carrier Containing Cytarabine and Daunorubicin in a Fixed 5:1 Molar Ratio for the Treatment of Relapsed and Refractory Acute Myeloid Leukemia

Eric J. Feldman, Jeffrey E. Lancet, Jonathan E. Kolitz et al. · Journal of Clinical Oncology · 2011 · 300 citations · Full text

Medicine, Clinical Pharmacokinetics, Pharmacology +17

Folate‐targeted imaging of activated macrophages in rats with adjuvant‐induced arthritis

Mary Jo Turk, Gert J. Breur, William R. Widmer et al. · Arthritis & Rheumatism · 2002 · 204 citations

Medicine, Immunology, Pharmacology +12

Targeting of folate receptor β on acute myeloid leukemia blasts with chimeric antigen receptor–expressing T cells

Rachel C. Lynn, Mathilde Poussin, Anna Kalota et al. · Blood · 2015 · 182 citations · Full text

Medicine, Hematology, Oncology +17